11:04 AM EDT, 07/28/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.78% to 1,489.58 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 15.3% and 11.2% respectively. They were followed by accommodations booking company trivago (TRVG) and biopharmaceutical company DBV Technologies ( DBVT ) , which increased 7.4% and 4.4% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and brewing company Anheuser-Busch InBev ( BUD ) , which dropped 25% and 4.8% respectively. They were followed by telecommunications operator Telefonica ( TEF ) and pharmaceutical company Novo Nordisk ( NVO ) , which lost 2.2% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and oil and gas company BP (BP), which rose 2% and 1.6% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and Bicycle Therapeutics ( BCYC ) , which were up 1.2% and 0.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which plunged 65%, followed by biopharmaceutical company NuCana ( NCNA ) , which was down 3.5%. They were followed by alcoholic beverage company Diageo ( DEO ) and biopharmaceutical company Amarin ( AMRN ) , which fell 2.7% and 1.6% respectively.